Randomized, Open-Label Phase 2 Study of Apalutamide plus Androgen Deprivation Therapy versus Apalutamide Monotherapy versus Androgen Deprivation Monotherapy in Patients with Biochemically Recurrent Prostate Cancer

PURPOSE: This randomized phase 2 study sought to assess the treatment effect of a finite duration of apalutamide with and without androgen deprivation therapy (ADT) in biochemically recurrent prostate cancer (BCR PC). Materials and Methods. Patients with BCR PC after primary definitive therapy and p...

Descripción completa

Detalles Bibliográficos
Autores principales: Aggarwal, Rahul, Alumkal, Joshi J., Szmulewitz, Russell Z., Higano, Celestia S., Bryce, Alan H., Lopez-Gitlitz, Angela, McCarthy, Sharon A., Miladinovic, Branko, McQuarrie, Kelly, Thomas, Shibu, Zhang, Ke, Small, Eric J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534720/
https://www.ncbi.nlm.nih.gov/pubmed/36212187
http://dx.doi.org/10.1155/2022/5454727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534720/
https://www.ncbi.nlm.nih.gov/pubmed/36212187
http://dx.doi.org/10.1155/2022/5454727

Ejemplares similares